These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21554201)

  • 21. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis viruses as aetiological agents of hepatocellular carcinoma.
    Alberti A; Pontisso P
    Ital J Gastroenterol; 1991; 23(7):452-6. PubMed ID: 1660332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear factor-kappaB and liver carcinogenesis.
    Arsura M; Cavin LG
    Cancer Lett; 2005 Nov; 229(2):157-69. PubMed ID: 16125305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].
    Koike K
    Nihon Rinsho; 1999 Jan; 57(1):213-9. PubMed ID: 10036965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
    Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
    Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-κB and STAT3 - key players in liver inflammation and cancer.
    He G; Karin M
    Cell Res; 2011 Jan; 21(1):159-68. PubMed ID: 21187858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiogenic activity of hepatitis B and C viruses.
    Vrancken K; Paeshuyse J; Liekens S
    Antivir Chem Chemother; 2012 Jan; 22(4):159-70. PubMed ID: 22182803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
    Bréchot C; Minami M; De Mitri S; Paterlini P
    Princess Takamatsu Symp; 1995; 25():199-209. PubMed ID: 8875625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
    Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
    Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
    Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Present status of hepatitis virus-associated hepatocellular carcinoma in Nagasaki Prefecture, Japan: a cross-sectional study of 1019 patients.
    Tanioka H; Omagari K; Kato Y; Nakata K; Kusumoto Y; Mori I; Furukawa R; Tajima H; Koga M; Yano M; Kohno S
    J Infect Chemother; 2002 Mar; 8(1):64-9. PubMed ID: 11957122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.
    Kasai Y; Takeda S; Takagi H
    Semin Surg Oncol; 1996; 12(3):155-9. PubMed ID: 8727603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma: risk factors other than HBV.
    Villa E; Melegari M; Scaglioni PP; Trande P; Cesaro P; Manenti F
    Ital J Gastroenterol; 1991; 23(7):457-60. PubMed ID: 1660333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma: possible etiologies in patients without serologic evidence of hepatitis B virus infection.
    Tabor E
    J Med Virol; 1989 Jan; 27(1):1-6. PubMed ID: 2537873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of environmental factors in the etiology of hepatocellular carcinoma].
    Tornai I
    Orv Hetil; 2010 Jul; 151(28):1132-6. PubMed ID: 20570793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.